サイクルオキシゲネーゼ-2による脂質媒介体生成におけるアスピリン誘発のスイッチに関するメカニズム的仮説
1Department of Drug Science and Technology, Via Pietro Giuria 9, 10125 Torino, Italy. paolo.tosco@unito.it
Journal of the American Chemical Society
|June 22, 2013
まとめ
プロスタグランジン産生におけるサイクロオキシゲナーゼ-2 (COX-2) のステレオ特異性は,ステリックシールドによって決定される. COX-2のアスピリンアセチル化はこれを変化させ,リピド媒介体の生成をシフトさせ,計算モデリングによって確認されています.
科学分野:
- バイオケミストリー バイオケミストリー
- 酵素学 酵素学とは
- 分子生物学は分子生物学である.
背景:
- サイクロオキシゲナーゼ (COX) 酵素は,アラキドン酸のステレオ固有の酸化を触媒化し,プロスタグランディンを産生する.
- COX-2の活性,特にそのステレオ特異性および産物分布は,特にアスピリン治療後のSer530アセチル化のような翻訳後の修正によって調節されます.
- COX-2の高いステレオスペシフィシティとアスピリン誘発の変異の効果の背後にある正確な分子機構は,まだ完全に理解されていません.
研究 の 目的:
- 酸化反応におけるサイクロオキシゲナーゼ-2 (COX-2) のステレオ特異性の分子基礎を解明する.
- COX-2のアスピリン治療後に観察された脂質媒介体生産のシフトの理由を説明する.
- COX-2のステレオ特異性に関するメカニズム的仮説を提案し,計算的に検証する.
主な方法:
- ステレオスペシフィシティの決定因子としてのステリックシールドに焦点を当てたメカニズム的仮説の開発.
- COX-2の酸素化パターンをシミュレートする計算モデルを作成.
- 本来のCOX-2とアスピリン阻害のCOX-2の両方の実験データに対するモデルの検証.
主要な成果:
- 提案された仮説は,COX-2酸化ステレオ特異性を支配する主要な要因としてステリックシールドを特定します.
- 計算モデルは,ネイティブのCOX-2の実験的酸素化パターンを正確に複製しています.
- このモデルは,アスピリンで抑制されたCOX-2で観察された変化した酸素化パターンを成功裏に再現しています.
結論:
- ステリックシールドは,COX-2触媒による酸素化で観察される高いステレオ特異性の重要な決定因子です.
- COX-2 の Ser530 のアスピリン誘発によるアセチル化により,ステリック制約が変化し,生成される脂質媒介体の種類と相対量のシフトにつながります.
- コンピューティング・モデリングは,酵素機構を理解し,薬物阻害のような改変の効果を予測するための強力なツールを提供します.
関連する概念動画
Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
